Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

Breakthrough for prostate cancer patients as NHS now offers life-extending drug - The new medication is suitable for patients ...

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...

Prostate cancer is the second-most common cancer in men. A new study from Thomas Jefferson University uncovered a new ...

The PROSTaid group, which meets monthly at The Cradock Arms in Leicester, aims to create a support group for men so they can ...

Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that ...

New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, ...

Prostate cancer is the second most commonly diagnosed cancer in men globally, according to the World Health Organisation (WHO ...

Bengaluru: In a significant global milestone in integrated surgical care, doctors at Fortis Hospital Bannerghatta Road, ...

A North Island College (NIC) biology instructor has received a $10,000 grant from Prostate Cancer Foundation Canada to give ...